No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
SGMO250117C500
- 2.20
- +0.25+12.82%
15min DelayTrading Dec 23 10:47 ET
2.20High2.20Low
2.20Open1.95Pre Close1 Volume9 Open Interest0.50Strike Price220.00Turnover394.61%IV11.94%PremiumJan 17, 2025Expiry Date1.91Intrinsic Value100Multiplier25DDays to Expiry0.29Extrinsic Value100Contract SizeAmericanOptions Type0.9795Delta0.0197Gamma1.21Leverage Ratio-0.0025Theta0.0003Rho1.18Eff Leverage0.0003Vega
Intraday
- 5D
- Daily
News
Sector Update: Health Care Stocks Mixed Premarket Thursday
Sangamo Shares Rally Premarket on License Deal With Astellas
Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Biggest Stock Movers Thursday: MU, MESO, and More
Express News | Sangamo Therapeutics Inc - Eligible for up to $1.3 Billion in Milestone Payments
Express News | Sangamo Therapeutics and Astellas Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases